Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 16 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Better Choice Company, Inc. (NYSE American: BTTR) Completes Merger with SRx Health, Will Rebrand as SRx Health Solutions Inc.
Better Choice Company (NYSE American: BTTR) announced the closing of its business combination with SRx…
-
Brera Holdings PLC’s (NASDAQ: BREA) S.S. Juve Stabia S.r.l Posts Largest Valuation Percentage Gain; Signals Club’s Growing Competitiveness
Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”)…